Pharmaceutical Commerce

MAY 7, 2025

The move bolsters the CDMOs commitment to cell and gene therapy by incorporating advanced manufacturing and fill-finish capabilities.

52

52

Drug Topics

MAY 7, 2025

Selarsdi is interchangeable for all indications of ustekinumab, including treatment of psoriatic arthritis, plaque psoriasis, Crohn disease, and ulcerative colitis.

FDA 527

FDA 527

PharmaVoice

MAY 7, 2025

RFK Jr.’s plan to ban TV advertising may shift more marketing attention to online platforms.

182

182

Drug Topics

MAY 7, 2025

In this episode of the podcast, Natalie DiPietro Mager, PharmD, PhD, sits down with Jasmine Cutler, PharmD, CPh.

343

343

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

STAT

MAY 7, 2025

Robert F. Kennedy Jr. holds his anti-vaccine beliefs with the strength of a religious conviction, writes rotavirus vaccine co-inventor Paul A. Offit.

Vaccines 145

Vaccines 145

Drug Topics

MAY 7, 2025

Patients often have anxiety about potential adverse effects, and experiencing adverse effects can affect patient adherence.

316

316

Drug Topics

MAY 7, 2025

Stanley V. Campbell, Jr., CEO of EagleForce Associates, Inc., and Yi Deng, PhD, Senior Vice President of Engineering at EagleForce, explore real-world examples of AI giving time back to pharmacists.

309

309

STAT

MAY 7, 2025

WASHINGTON — In his first address to FDA staff on Wednesday, Vinay Prasad emphasized his commitment to evidence, his admiration for agency employees, and his desire to serve the American public.  The new director of the Center for Biologics Evaluation and Research sounded very different from his online firebrand persona. He struck a humble, self-deprecating, and even earnest tone, calling the American people the agency’s “number one stakeholder.

FDA 142

FDA 142

Drug Topics

MAY 7, 2025

Stanley V. Campbell, Jr., CEO of EagleForce Associates, Inc., and Yi Deng, PhD, Senior Vice President of Engineering at EagleForce, discuss how AI is being used to benefit patients.

282

282

PhRMA

MAY 7, 2025

PhRMA submitted comments to the U.S. Department of Commerce on its Section 232 investigation of pharmaceuticals and pharmaceutical ingredients imported to the United States.

130

130

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Topics

MAY 7, 2025

A phase 2 study found 95% of patients achieved a sustained virologic response at 12 weeks regardless of treatment adherence.

247

247

PharmaVoice

MAY 7, 2025

A vocal opponent of his predecessor Peter Marks, Dr. Vinay Prasad will now lead the office tasked with reviewing some genetic medicines, adding more uncertainty to an already struggling field of research.

FDA 130

FDA 130

Drug Topics

MAY 7, 2025

A panelist discusses how transforming pharmacy staff roles by training technicians to handle clinical programs such as point-of-care testing creates a more efficient workflow system, similar to how physicians work with nurses.

247

247

STAT

MAY 7, 2025

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. “Just when I thought I was out, they pull me back in.” — Michael Corleone, “Godfather Part III.”  I had this thought Monday while out for a walk with Bo: I’m going to write an entirely politics-free newsletter this week.

FDA 129

FDA 129

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Drug Topics

MAY 7, 2025

A panelist discusses how medical billing for point-of-care testing represents a significant revenue opportunity for pharmacies. Further, though the process will be initially unfamiliar, pharmacists should learn and control it rather than outsourcing it.

Community Pharmacies 247

Community Pharmacies 247

STAT

MAY 7, 2025

Innovation in cancer detection, treatment, and prevention is stirring excitement today, accelerated by advances in artificial intelligence and other technological tools wielded by scientists, physicians, and even patients. Still, serious gaps remain between theory and reality, experts said Tuesday. There’s a gap in access. There’s a gap between clinical guidance and clinical practice.

121

121

pharmaphorum

MAY 7, 2025

Various industries have welcomed news of a trade deal between the UK and India, but Britain's pharma sector isn't among them

101

101

STAT

MAY 7, 2025

A federal judge has sided with the U.S. Food and Drug Administration over a decision last year to remove two Eli Lilly drugs — the Zepbound weight loss medicine and the Mounjaro diabetes treatment — from a shortages list kept by the agency. The move means that patients will no longer have access to cheaper versions from compounding pharmacies.

Compounding 119

Compounding Compounding Pharmacies FDA 119

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

MAY 7, 2025

Intravenous immunoglobulin (IVIG) treatment for dermatologic conditions shows effectiveness but poses risks of kidney decline and thromboembolism, necessitating careful monitoring.

94

94

STAT

MAY 7, 2025

Four years ago, an ambitious pharmaceutical industry venture to tackle antibiotic resistance launched to acquire or invest in small companies that can develop two to four novel antibiotics by 2030 — and replenish the global supply chain with needed treatments. The effort began with $1 billion in backing from several large drugmakers, the European Investment Bank and Wellcome Trust.

118

118

Pharmaceutical Technology

MAY 7, 2025

Venture philanthropy organisation Solve FSHD has announced an investment of $3m in Armatus Bio to support the development of ARM-201.

93

93

STAT

MAY 7, 2025

Marea Therapeutics said Wednesday that an experimental drug reduced by half a type of blood fat called remnant cholesterol — a mid-stage study result that paves the way for further trials and could lead to a new way of treating cardiovascular disease.  Remnant cholesterol is distinct from LDL (bad) or HDL (good) cholesterol, and elevated levels are associated with a higher risk of serious cardiovascular events even in patients prescribed standard cholesterol-lowering medicines, said

114

114

Pharmacy Times

MAY 7, 2025

UPMC enhances care for patients with heart failure through integrated pharmacy and cardiology team collaboration.

89

89

STAT

MAY 7, 2025

No one goes to medical school because they want to type quickly while listening to patients talk. But that’s what practicing medicine means for many today: fingers flying over the keyboard to log data. Later, they will use that information to create a note for the patient’s file. Technology now offers a solution to this problem in the form of the AI ambient scribe, which records the encounter between physician and patient and then generates the summarizing note for the patient

Medical Schools 111

Medical Schools 111

Pharmacy Times

MAY 7, 2025

The 12.5-mg dose tablet enhances hypertension treatment options and reduces adverse effects for patients.

FDA 86

FDA 86

STAT

MAY 7, 2025

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. Biotech was not faring well yesterday, after we got the news that Vinay Prasad was chosen to be the next director of the FDA’s biologics center.

FDA 110

FDA 110

Fierce Healthcare

MAY 7, 2025

CMS is notifying insurers Congress may appropriate money toward cost-sharing reduction payments, causing upheaval in the Affordable Care Act market,

Insurance 85

Insurance 85

STAT

MAY 7, 2025

Y ou’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine.  Sign up to get it  delivered in your inbox every Wednesday.   I love trying the local ice cream when I visit a different city. I recently had the best ice cream experience of my life at Woodside Farm Creamery near Wilmington, Delaware — they sell their ice cream cones/bowls by the ounce and have great, funky

108

108

Fierce Healthcare

MAY 7, 2025

Oscar Health's stock increased by 30% after its first quarter earnings, but company executives weighed in on the potential adverse consequences of cost-sharing reductions, ACA enhanced subsidy expirations and a shortened enrollment window.

85

85

STAT

MAY 7, 2025

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Good morning, and happy Wednesday. I’m seeing Japanese Breakfast perform in Boston tonight. (Michelle Zauner, the band’s frontwoman, is actually Korean-American, not Japanese. I highly recommend her memoir, “Crying in H Mart.

99

99

pharmaphorum

MAY 7, 2025

AstraZeneca and Daiichi Sankyo's Enhertu has been shown to provide a benefit in a phase 3 trial in early-stage breast cancer for the first time

82

82

STAT

MAY 7, 2025

In January, San Francisco’s Union Square was bustling with hordes of drug developers and investors, pounding the pavement on their way from meeting to meeting. But Rohan Ganesh, an investor at the VC firm Obvious Ventures, wasn’t among them. He only agreed to hear one company’s pitch during this year’s J.P. Morgan Healthcare Conference.

97

97

Fierce Healthcare

MAY 7, 2025

The university and its affiliated hospitals have now paid out over $1 billion to hundreds of former patients of Robert Hadden, who hasn't practiced since 2012 and was convicted and sentenced in 2023.

Hospitals 76

Hospitals 76